Osaka, Japan

Michio Sowa

This inventor holds 1 USPTO granted patent. Top assignee: Tosoh Corporation. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michio Sowa: Innovator in Cancer Diagnosis

Introduction

Michio Sowa is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of cancers affecting the digestive organs. His innovative work has the potential to improve early diagnosis and treatment options for patients.

Latest Patents

Michio Sowa holds a patent for "Methods for diagnosis of colon, stomach and pancreatic cancer using antibodies specific for a mucin-type carbohydrate chain." This patent describes methods for diagnosing cancers of the digestive organs, specifically targeting stomach, colon, and pancreatic cancers. The use of antibodies specific for a mucin-type carbohydrate chain enhances the accuracy of cancer detection.

Career Highlights

Sowa is associated with Tosoh Corporation, a company known for its advancements in analytical and diagnostic technologies. His work at Tosoh has allowed him to focus on innovative solutions that address critical health issues. With a patent portfolio that includes 1 patent, Sowa continues to contribute to the medical field.

Collaborations

Throughout his career, Michio Sowa has collaborated with notable colleagues, including Takashi Saito and Keiichi Murayama. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Michio Sowa is a dedicated inventor whose work in cancer diagnostics is paving the way for advancements in medical technology. His contributions are vital for improving patient outcomes in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…